# US 6,727,265 B2 · Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,265 B2
- Document ID: US6727265B2
- Status: Granted
- Kind: B2
- Application number: 10/420,032
- Filed: 2003-04-15
- Published: 2003-10-02
- Granted: 2004-04-27
- Earliest claimed: 2000-10-18
- Assignees: Parker Hughes Institute
- Inventors: Fatih M. Uckun; Taracad K. Venkatachalam
- Web page: https://patentgrep.com/patent/US6727265B2

## CPC

- C07D 213/75: Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention provides compounds which inhibit reverse transcriptase (RT) and which inhibit replication of a retrovirus, such as human immunodeficiency virus-1 (HIV-1). The compound of the invention are phenoxyethyl-thiourea-pyridines. The invention additionally provides a method for inhibiting reverse transcriptase activity of a retrovirus, such as HIV-1, comprising contacting the retrovirus with a compound of the invention. The invention additionally provides a method for inhibiting replication of a retrovirus, such as HIV-1, comprising contacting the retrovirus with a compound of the invention.

## Claims

### Claim 1

A compound of the formula:
wherein
R1 is H, hydroxyl or halo;
n is an integer from 0 to 5;
R is C1-C6 alkyl, alkoxy, hydroxyl, amino, or halo.

### Claim 2 (depends on 1)

A compound of claim 1 wherein
R1 is hydrogen or a halo;
and n is 0.

### Claim 3

A compound of the formula:

### Claim 4

A compound of the formula:

### Claim 5

A compound of the formula:

### Claim 6 (depends on 1)

A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 1 and a pharmaceutically acceptable carrier or diluent.

### Claim 7 (depends on 3)

A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 3 and a pharmaceutically acceptable carrier or diluent.

### Claim 8 (depends on 4)

A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 4 and a pharmaceutically acceptable carrier or diluent.

### Claim 9 (depends on 5)

A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 5 and a pharmaceutically acceptable carrier or diluent.

### Claim 10 (depends on 1)

A method for inhibiting HIV reverse transcriptase comprising contacting said HIV with an effective HIV reverse transcriptase inhibitory amount of a compound of claim 1.

### Claim 11 (depends on 3)

A method for inhibiting HIV reverse transcriptase comprising contacting said HIV with an effective HIV reverse transcriptase inhibitory amount of a compound of claim 3.

### Claim 12 (depends on 4)

A method for inhibiting HIV reverse transcriptase comprising contacting said HIV with an effective HIV reverse transcriptase inhibitory amount of a compound of claim 4.

### Claim 13 (depends on 5)

A method for inhibiting HIV reverse transcriptase comprising contacting said HIV with an effective HIV reverse transcriptase inhibitory amount of a compound of claim 5.

### Claim 14 (depends on 1)

A method for treating HIV infection in a subject comprising administering to said subject an anti-HIV effective amount of a compound of claim 1.

### Claim 15 (depends on 3)

A method for treating HIV infection in a subject comprising administering to said subject an anti-HIV effective amount of a compound of claim 3.

### Claim 16 (depends on 4)

A method for treating HIV infection in a subject comprising administering to said subject an anti-HIV effective amount of a compound of claim 4.

### Claim 17 (depends on 5)

A method for treating HIV infection in a subject comprising administering to said subject an anti-HIV effective amount of a compound of claim 5.

### Claim 18 (depends on 1)

A method for treating drug-resistant HIV in a subject comprising administering to said subject a drug-resistant HIV treating effective amount of claim 1.

### Claim 19 (depends on 3)

A method for treating drug-resistant HIV in a subject comprising administering to said subject a drug-resistant HIV treating effective amount of claim 3.

### Claim 20 (depends on 4)

A method for treating drug-resistant HIV in a subject comprising administering to said subject a drug-resistant HIV treating effective amount of claim 4.

### Claim 21 (depends on 5)

A method for treating drug-resistant HIV in a subject comprising administering to said subject a drug-resistant HIV treating effective amount of claim 5.
